IP Library Assignment 064458/0841
Patent Assignment
Reel/Frame 064458/0841

Assignment of Assignor's Interest

Recorded: 2023-08-01 Pages: 2
Assignor
VON RAUMER, MARKUS
Executed: 2023-06-12
Assignee
IDORSIA PHARMACEUTICALS LTD
HEGENHEIMERMATTWEG 91, ALLSCHWIL, 4123, SWITZERLAND
Covered Property (1)
A Crystalline Form of (4-Methyl-2-[1,2,3]Triazol-2-Yl-Phenyl)-[(R)-3-(3-[1,2,3]Triazol-2-Yl-Benzyl)-Morpholin-4-Yl]-Methanone
Application: 18/263,847 →
Publication: US 2024/0116913
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Patent Security Agreement Jun 25, 2026
From: IDORSIA PHARMACEUTICALS LTD
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 076038/0461 →